United Therapeutics Corporation Cash Flow Quality Index
United Therapeutics Corporation cash flow quality index. United Therapeutics Corporation (UTHR) has a Cash Flow Quality Index of 0.94x as of June 2026. Operating cash flow of $313.60 Million is below net income of $333.00 Million, suggesting accrual-heavy earnings not yet converted to cash. See UTHR FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of United Therapeutics Corporation (2004–2025)
Cash flow quality index of United Therapeutics Corporation from 2004 to 2025. Historical Cash Flow Quality Index for United Therapeutics Corporation across 20 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore United Therapeutics Corporation (UTHR) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
United Therapeutics Corporation Cash Flow Quality Index by Year (2004–2025)
United Therapeutics Corporation cash flow quality index by year from 2004 to 2025. Year-by-year earnings quality comparison for United Therapeutics Corporation. For the full cash flow conversion analysis, see UTHR cash generation efficiency.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.17x | $1.56 Billion | $1.33 Billion | ▲ +5.3% |
| 2024 | 1.11x | $1.33 Billion | $1.20 Billion | ▲ +11.8% |
| 2023 | 0.99x | $978.00 Million | $984.80 Million | ▼ -10.0% |
| 2022 | 1.10x | $802.50 Million | $727.30 Million | ▼ -12.2% |
| 2021 | 1.26x | $598.20 Million | $475.80 Million | ▼ -14.4% |
| 2020 | 1.47x | $755.70 Million | $514.80 Million | ▲ +11.1% |
| 2018 | 1.32x | $778.40 Million | $589.20 Million | ▲ +16.4% |
| 2017 | 1.13x | $474.20 Million | $417.90 Million | ▲ +25.8% |
| 2016 | 0.90x | $643.60 Million | $713.70 Million | ▲ +53.5% |
| 2015 | 0.59x | $382.80 Million | $651.60 Million | ▼ -43.8% |
| 2014 | 1.04x | $355.30 Million | $340.10 Million | ▼ -57.1% |
| 2013 | 2.44x | $425.27 Million | $174.56 Million | ▲ +129.2% |
| 2012 | 1.06x | $323.63 Million | $304.44 Million | ▼ -7.4% |
| 2011 | 1.15x | $250.19 Million | $217.87 Million | ▼ -42.5% |
| 2010 | 2.00x | $211.53 Million | $105.92 Million | ▼ -61.0% |
| 2009 | 5.12x | $99.72 Million | $19.46 Million | ▲ +107.9% |
| 2007 | 2.46x | $48.95 Million | $19.86 Million | ▲ +269.1% |
| 2006 | 0.67x | $49.39 Million | $73.97 Million | ▲ +0.6% |
| 2005 | 0.66x | $43.17 Million | $65.02 Million | ▼ -50.6% |
| 2004 | 1.34x | $20.78 Million | $15.45 Million | — |